|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 747801-747825 of 2348685 (93948 Page(s) Totally)
<< < 29908 29909 29910 29911 29912 29913 29914 29915 29916 29917 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2016 |
Secukinumab demonstrates an acceptable safety profile in moderate to severe plaque psoriasis: Pooled analysis of 10 phase 2/3 studies
|
Foley, P.; Griffiths, C.; Reich, K.; Leonardi, C. L.; Blauvelt, A.; Mehta, N. N.; Tsai, T. F.; Gong, Y.; Papavassilis, C.; Huang, J.; Fox, T.; van de Kerkhof, P.; 蔡呈芳 |
| 臺大學術典藏 |
2019-09-16T09:25:16Z |
Secukinumab demonstrates superior efficacy and a faster response in clearing skin in Asian subjects with moderate to severe plaque psoriasis compared with ustekinumab: Subgroup analysis from the CLEAR study
|
Dee, Cathleen Michelle A.;Lee, Joo Heung;Guana, Adriana;Lee, Seung Chul;Huang, Yu Huei;Lee, Min Geol;Aw, Derrick Chen Wee;Bao, Weibin;Kim, Tae Gyun;TSEN-FANG TSAI; TSEN-FANG TSAI; Kim, Tae Gyun; Bao, Weibin; Aw, Derrick Chen Wee; Lee, Min Geol; Huang, Yu Huei; Lee, Seung Chul; Guana, Adriana; Lee, Joo Heung; Dee, Cathleen Michelle A. |
| 臺大學術典藏 |
2020-10-22T07:27:41Z |
Secukinumab demonstrates superior efficacy and a faster response in clearing skin in Asian subjects with moderate to severe plaque psoriasis compared with ustekinumab: Subgroup analysis from the CLEAR study
|
Dee C.M.A.; Guana A.; TSEN-FANG TSAI; Bao W.; Aw D.C.-W.; Kim T.-G.; Lee S.-C.; Lee J.-H.; Huang Y.-H.; Lee M.-G. |
| 中山醫學大學 |
2020 |
Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1
|
Tseng, JC; Wei, JCC; Deodhar, A; Martin, R; Porter, B; McCreddin, S; Talloczy, Z |
| 臺大學術典藏 |
2019 |
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study
|
Tha?I D.;Puig L.;Reich K.;Tsen-Fang Tsai;Tyring S.;Kingo K.;Ziv M.;Pinter A.;Vender R.;Lacombe A.;Xia S.;Bhosekar V.;Gilloteau I.;Guana A.;Blauvelt A.; Tha?i D.; Puig L.; Reich K.; TSEN-FANG TSAI; Tyring S.; Kingo K.; Ziv M.; Pinter A.; Vender R.; Lacombe A.; Xia S.; Bhosekar V.; Gilloteau I.; Guana A.; Blauvelt A. |
| 國立臺灣大學 |
2015 |
Secukinumab efficacy and safety in Asian subjects with moderate to severe plaque psoriasis: Pooled analysis from the FIXTURE and ERASURE phase III clinical studies
|
Lee, Jeung-Hoon; Morita, Akimichi; Tsai, Tsen-Fang; Zheng, Eugene; Ko, Luke; Fox, Todd; Langley, Richard; 蔡呈芳 |
| 臺大學術典藏 |
2020-07 |
Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment
|
TSEN-FANG TSAI; Tsen-Fang Tsai |
| 國立臺灣大學 |
2014 |
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
|
Langley, Richard G.; Elewski, Boni E.; Lebwohl, Mark; Reich, Kristian; Griffiths, Christopher E. M.; Papp, Kim; Puig, Lluis; Nakagawa, Hidemi; Spelman, Lynda; Sigurgeirsson, Bardur; Rivas, Enrique; Tsai, Tsen-Fang; Wasel, Norman; Tyring, Stephen; Salko, Thomas; Hampele, Isabelle; Notter, Marianne; Karpov, Alexander; Helou, Silvia; Papavassilis, Charis; 蔡呈芳 |
| 臺大學術典藏 |
2018-09-10T15:02:46Z |
Secukinumab in plaque psoriasis - Results of two phase 3 trials
|
Langley, R.G. and Elewski, B.E. and Lebwohl, M. and Reich, K. and Griffiths, C.E.M. and Papp, K. and Puig, L. and Nakagawa, H. and Spelman, L. and Sigurgeirsson, B. and Rivas, E. and Tsai, T.-F. and Wasel, N. and Tyring, S. and Salko, T. and Hampele, I. and Notter, M. and Karpov, A. and Helou, S. and Papavassilis, C.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:28:03Z |
Secukinumab in plaque psoriasis - Results of two phase 3 trials
|
Karpov A.; Hampele I.; Notter M.; Salko T.; Tyring S.; Langley R.G.; Elewski B.E.; Lebwohl M.; Reich K.; Griffiths C.E.M.; Papp K.; Puig L.; Nakagawa H.; Spelman L.; Sigurgeirsson B.; Rivas E.; TSEN-FANG TSAI; Wasel N.; Helou S.; Papavassilis C. |
| 臺大學術典藏 |
2018-09-10T18:07:35Z |
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
|
Wang, T.-S. and Chan, C.-C. and Chiu, H.-Y. and Tsai, T.-F.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2017 |
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
|
Wang T.-S.;Chan C.-C.;Chiu H.-Y.;Tsen-Fang Tsai; Wang T.-S.; Chan C.-C.; Chiu H.-Y.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2022-01-11T06:49:36Z |
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
|
Wang T.-S.; Chan C.-C.; HSIEN-YI CHIU; Tsai T.-F. |
| 國立臺灣大學 |
2014 |
Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response and Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)
|
Elewski, B.; Lebwohl, M.; Papp, K.; Nakagawa, H.; Sigurgeirsson, B.; Tsai, T. -F.; Tyring, S.; Hampele, I.; Karpov, A.; Helou, S.; Papavassilis, C.; 蔡呈芳 |
| 國立臺灣大學 |
2015 |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
|
Thaci, Diamant; Blauvelt, Andrew; Reich, Kristian; Tsai, Tsen-Fang; Vanaclocha, Francisco; Kingo, Kuelli; Ziv, Michael; Pinter, Andreas; Hugot, Sophie; You, Ruquan; Milutinovic, Marina; 蔡呈芳 |
| 臺大學術典藏 |
2018-09-10T15:28:28Z |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
|
Tha?i, D. and Blauvelt, A. and Reich, K. and Tsai, T.-F. and Vanaclocha, F. and Kingo, K. and Ziv, M. and Pinter, A. and Hugot, S. and You, R. and Milutinovic, M.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:58Z |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
|
Tha?i D.; Blauvelt A.; Reich K.; TSEN-FANG TSAI; Vanaclocha F.; Kingo K.; Ziv M.; Pinter A.; Hugot S.; You R.; Milutinovic M. |
| 臺大學術典藏 |
2018-09-10T18:07:35Z |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1?year: Results from the CLEAR study
|
Blauvelt, A. And Reich, K. And Tsai, T.-F. And Tyring, S. And Vanaclocha, F. And Kingo, K. And Ziv, M. And Pinter, A. And Vender, R. And Hugot, S. And You, R. And Milutinovic, M. And Tha?I, D.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:53Z |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1?year: Results from the CLEAR study
|
Blauvelt A.; Reich K.; TSEN-FANG TSAI; Tyring S.; Vanaclocha F.; Kingo K.; Ziv M.; Pinter A.; Vender R.; Hugot S.; You R.; Milutinovic M.; Tha?i D. |
| 臺大學術典藏 |
2019-02-13T05:40:17Z |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
|
TSEN-FANG TSAI; TSEN-FANG TSAI |
| 國立臺灣大學 |
2016 |
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
|
van de Kerkhof, Peter C. M.; Griffiths, Christopher E. M.; Reich, Kristian; Leonardi, Craig L.; Blauvelt, Andrew; Tsai, Tsen-Fang; Gong, Yankun; Huang, Jiaqing; Papavassilis, Charis; Fox, Todd; 蔡呈芳 |
| 臺大學術典藏 |
2018-09-10T15:39:05Z |
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
|
Van De Kerkhof, P.C.M. and Griffiths, C.E.M. and Reich, K. and Leonardi, C.L. and Blauvelt, A. and Tsai, T.-F. and Gong, Y. and Huang, J. and Papavassilis, C. and Fox, T.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:55Z |
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
|
Fox T.; Papavassilis C.; Huang J.; Gong Y.; TSEN-FANG TSAI; Blauvelt A.; Leonardi C.L.; Griffiths C.E.M.; Reich K.; Van De Kerkhof P.C.M. |
| 國立臺灣大學 |
2015 |
Secukinumab treatment shows no evidence for reactivation of previous or latent TB infection in subjects with psoriasis: A pooled phase 3 safety analysis
|
Tsai, Tsen-Fang; Blauvelt, Andrew; Gong, Yankun; Huang, Jiaqing; Fox, Todd; 蔡呈芳 |
| 國立臺灣師範大學 |
2016-03-22T06:50:46Z |
Secular Change of Diurnal Temperature Range in Taiwan (1901~2008)
|
翁叔平; 黃燕儀 |
Showing items 747801-747825 of 2348685 (93948 Page(s) Totally)
<< < 29908 29909 29910 29911 29912 29913 29914 29915 29916 29917 > >>
View [10|25|50] records per page
|
